Literature DB >> 6644439

Effect of caffeine on control of breathing in infantile apnea.

J V Aranda, T Turmen, J Davis, T Trippenbach, D Grondin, R Zinman, G Watters.   

Abstract

Abnormalities in control of breathing have been associated with near-miss sudden infant death syndrome. Because caffeine is a respiratory stimulant, its effect on breathing pattern was evaluated in 12 infants with infantile apnea. Caffeine induced a significant increase in ventilation, tidal volume, and mean inspiratory flow. In contrast, no changes were noted in inspiratory time, expiratory time, or total cycle duration. These effects were observed with plasma concentrations of caffeine ranging from 8 to 20 mg/L. Caffeine increases ventilation mainly by increasing central inspiratory drive, and not be effective timing (T1/TTOT). This drug may be of value in near-miss SIDS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644439     DOI: 10.1016/s0022-3476(83)80735-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates.

Authors:  Sandrine Micallef; Billy Amzal; Véronique Bach; Karen Chardon; Pierre Tourneux; Frédéric Y Bois
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Caffeine and alcohol as risk factors for sudden infant death syndrome. Nordic Epidemiological SIDS Study.

Authors:  B Alm; G Wennergren; G Norvenius; R Skjaerven; N Oyen; K Helweg-Larsen; H Lagercrantz; L M Irgens
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 3.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 4.  The Role of Caffeine in Noninvasive Respiratory Support.

Authors:  Nicole R Dobson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2016-09-28       Impact factor: 3.430

5.  Heavy caffeine intake in pregnancy and sudden infant death syndrome. New Zealand Cot Death Study Group.

Authors:  R P Ford; P J Schluter; E A Mitchell; B J Taylor; R Scragg; A W Stewart
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

6.  Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.

Authors:  Nicole R Dobson; Ravi M Patel; P Brian Smith; Devon R Kuehn; Jennifer Clark; Shilpa Vyas-Read; Amy Herring; Matthew M Laughon; David Carlton; Carl E Hunt
Journal:  J Pediatr       Date:  2014-01-23       Impact factor: 4.406

7.  Apnoea and seizures.

Authors:  J M Davis; K Metrakos; J V Aranda
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

8.  Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial.

Authors:  Janneke Dekker; Stuart B Hooper; Jeroen J van Vonderen; Ruben S G M Witlox; Enrico Lopriore; Arjan B Te Pas
Journal:  Pediatr Res       Date:  2017-05-17       Impact factor: 3.756

9.  Effects of theophylline on ventilatory response to hypoxic challenge.

Authors:  J Milerad
Journal:  Arch Dis Child       Date:  1987-12       Impact factor: 3.791

Review 10.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.